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Available online 6 November 2014Abstract Krüppel-like factor 5 (KLF5) is a pro-proliferative transcription factor that is expressed in dividing epithelial cells of
the intestinal crypt. Leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) has been identified as a stem cell
marker in both small intestinal and colonic epithelial cells. To determine whether KLF5 regulates proliferation of intestinal
stem cells, we investigated the effects of Klf5 deletion specifically from the intestinal stem cells in adult mice. Mice with
inducible intestinal stem cell-specific deletion of Klf5 (Lgr5-Klf5fl/fl) were injected with tamoxifen for 5 consecutive days to
induce Lgr5-driven Cre expression. Intestinal and colonic tissues were examined by immunohistochemistry at various time
points up to 112 days following start of tamoxifen treatment. Klf5 is co-localized in the crypt-based columnar (CBC) cells that
express Lgr5. By 11 days following the start of tamoxifen treatment, Lgr5-positive crypts from which Klf5 was deleted
exhibited a loss of proliferation that was accompanied by an increase in apoptosis. Beginning at 14 days following the start of
tamoxifen treatment, both Klf5 expression and proliferationwere re-established in the transit-amplifying epithelial cells but not in
the Lgr5-positive CBC cells. By 112 days post-treatment, up to 90% of the Lgr5-positive cells fromwhich Klf5was deleted were lost
from the intestinal crypts. These results indicate a critical role for KLF5 in the survival and maintenance of intestinal stem cells.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).are further divided into stem cells and transit-amplifying (TA)Introduction
The mammalian intestinal epithelium is comprised of a single
layer of columnar cells that are divided into two distinct
compartments, a proliferative zone and a differentiated zone.
The differentiated epithelial cells populate the villus and surface
epithelium of the small intestine and the colon, respectively.
The proliferative epithelial cells are confined to the crypts and⁎ Corresponding author. Fax: +1 631 444 3144.
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(http://creativecommons.org/licenses/by-nc-nd/3.0/).cells. TA cells are capable of rapidly dividing after which they
differentiate andmove out of the proliferating zone. TA cells are
subsequently replenished from the pool of stem cells that lie
immediately beneath them (van der Flier and Clevers, 2009).
Constant cell division in the proliferative zone results in upward
movement of epithelial cells along the crypt–villus axis until
they undergo apoptosis and are sloughed off at the surface of
the epithelium. The differentiated epithelial cells are divided
into absorptive (enterocytes) and secretory (goblet and
enteroendocrine cells) lineages in both the small and large
bowel (van der Flier and Clevers, 2009).is an open access article under the CC BY-NC-ND license
11Klf5 in intestinal stem cell proliferation and survivalAdult stem cells have been traditionally defined as undiffer-
entiated cells that have the capacity to undergo self-renewal
and proliferate while retaining the ability to differentiate
into multiple cell types (multipotency) in various situations
including regeneration after injury (Potten and Loeffler,
1990). In the intestinal epithelial tissue, stem cells have
long been considered to reside at the bottom of the crypt
(Potten et al., 1974; Cheng and Leblond, 1974), within the first
4–5 cells from the very bottom (Bjerknes and Cheng, 1981).
Monoclonality of intestinal crypts from single progenitors has
also been well established (Ponder et al., 1985). Several labs
have laid claim to identifying the location of intestinal adult
stem cells. A convincing claim was that the cell at position +4
from the bottom of the crypt is the “actual stem cell” due to its
label retention capacity, slow division rate and ability to
regenerate upon crypt damage (Potten et al., 1974, 1997;
Marshman et al., 2002). However, the crypt-based columnar
(CBC) cells, first described in 1974 (Cheng and Leblond, 1974),
were also proposed as the putative small intestinal stem cells
(Bjerknes and Cheng, 1981). There were two proposed models
for the maintenance of the stem cell population; immortal or
asymmetric model and the stochastic or symmetric model. The
immortal model was based on the idea of asymmetric
segregation of DNA strands in the dividing stem cells giving
rise to two distinct daughter cells, one stem cell and the other
a TA cell (Potten et al., 2002). This model has been challenged
by the stochastic model in which the segregation of DNA in the
stem cells happens randomly (Schepers et al., 2011). It is
suggested that the crypt stem cells possess similar fates and
the crypts achieve monoclonality over time through “neutral
drift” suggesting a pool of equipotent stem cells (Snippert et
al., 2010; Lopez-Garcia et al., 2010).
Intestinal stem cells have been identified by various
markers, such as musashi-1 (Msi1), hairy enhancer of split-1
(Hes1), CD133, leucine-rich repeats and immunoglobulin-like
domains protein 1 (Lrig1) (Kayahara et al., 2003; Potten et al.,
2003; O'Brien et al., 2007; Wong et al., 2012). More recently
the leucine-rich repeat-containing G-protein coupled recep-
tor 5 (Lgr5) has also been established as the protein marking
homeostatic intestinal epithelial stem cells (Barker et al.,
2007). Lgr5 is expressed exclusively in the CBC cell
compartment. Using mice expressing Cre recombinase from
the Lgr5 promoter in lineage tracing experiments, it was
shown that Lgr5-positive CBC cells gave rise to all the
differentiated cell types in the intestinal epithelium (Barker
et al., 2007). Furthermore, several stem cell genes, including
Ascl2 and Olfm4, were also expressed in the Lgr5-positive
stem cell compartment (Munoz et al., 2012). Finally, single
Lgr5-positive stem cells are capable of generating crypt-villus
structures in vitro (Sato et al., 2009).
Krüppel-like factors (KLFs) are zinc finger-containing
transcription factors that are involved in numerous cellular
processes including differentiation, proliferation, cell cycle
and apoptosis (Ghaleb et al., 2005; McConnell et al., 2007;
McConnell and Yang, 2010). In the intestinal epithelium, KLF4
and KLF5 are expressed in the differentiated and proliferating
compartments, respectively (Ghaleb et al., 2005; McConnell
et al., 2007; McConnell and Yang, 2010). KLF5 has been shown
to regulate proliferation in the intestinal crypts both during
homeostasis (McConnell et al., 2011; Nandan et al., 2014) and
during tumorigenesis (Nandan et al., 2008, 2010; McConnell
et al., 2009). Both whole-body homozygous deletion of Klf5(Shindo et al., 2002) and villin–Cre mediated intestine-specific
deletion in mice (McConnell et al., 2011) were not well
tolerated. Inducible intestine-specific deletion of Klf5 in mice
led to a phenotype that showed impaired proliferation followed
by a regenerative response (Nandan et al., 2014).
In the current study, we focused on the effects of inducible
Klf5 deletion from the Lgr5-expressing intestinal stem cells
using the Lgr5-EGFP-IRES-CreERT2 mice (Barker et al., 2007).
The impact of such deletion was examined both at short-term,
or acute (up to 11 days following the start of tamoxifen
treatment), and long-term or chronic (up to 112 days). Upon
acute deletion of Klf5 from intestinal stem cells, we observed
a loss of Klf5 expression starting initially from the bottom and
gradually extending to the top of the crypt. We also noticed a
decrease in proliferation and a corresponding increase in
apoptosis within the crypt epithelium when Klf5 was deleted.
The impact of chronic Klf5 deletion from the mouse intestinal
stem cells was characterized by the recovery of both Klf5
expression and proliferation in TA cells but not in the
Lgr5-positive CBC cells, the majority of which were lost by
112 days following tamoxifen treatment. These results indi-
cate an important role for Klf5 in themaintenance and survival
of the intestinal stem cells.
Methods
Mice
All studies involving mice were approved by the Stony Brook
University Institutional Animal Care and Use Committee
(IACUC) and maintained on a 12:12 h light–dark cycle.
C57BL/6 J mice carrying Klf5 alleles flanked by loxP sites
(Klf5fl/fl) were previously described (Takeda et al., 2010)
and graciously provided by Dr. Ryozo Nagai. C57BL/6 mice
carrying the inducible Cre recombinase gene under regulation
of the Lgr5 promoter (Lgr5-EGFP-IRES-CreERT2 mice; hence-
forth designated as Lgr5-Cre) were purchased from Jackson labs
(ME, USA). To establish Lgr5-EGFP-IRES-CreERT2/Klf5fl/fl (des-
ignated as Lgr5-Klf5fl/fl) mice, Klf5fl/fl mice were initially
crossed with Lgr5-Cre mice and its progeny then backcrossed to
Klf5fl/fl mice. For all experiments, Lgr5-Cre mice were used as
controls. Tamoxifen treatment of mice was per protocol
previously described (el Marjou et al., 2004) (Suppl. Fig. 1).
Eight week old Lgr5-Klf5fl/fl and Lgr5-Cre mice were injected
intraperitoneally (I.P.) with 1 mg of tamoxifen (10 mg/ml,
dissolved in sterile corn oil, Sigma, MO, USA) for five con-
secutive days. Animals were sacrificed on days 3, 5, 7 and 11
after the start of tamoxifen injections for short-term (acute)
tamoxifen-treatment study (Suppl. Fig. 1A) and on days 14, 28,
56 and 112 for the long-term (chronic) tamoxifen-treatment
study (Suppl. Fig. 1B).
Antibodies
Antibodies used in the experiments were previously described
(Nandan et al., 2014). Klf5 rabbit polyclonal antibody (Santa
Cruz Biotechnologies, CA, USA; Cat# sc-22797) was used at
1:150 dilution. Rabbit monoclonal anti-Ki67 antibody was
purchased from Biocare Medical (CA, USA; Cat# CRM 325) and
used at 1:500 dilutions. Chicken polyclonal anti-GFP antibody
was purchased from Millipore (MA, USA; Cat# AB16901) was
12 M.O. Nandan et al.used for immunofluorescence staining at 1:500 dilution.
Rabbit polyclonal cleaved caspase 3 antibody was purchased
from Cell Signaling (MA, USA; Cat# 9664) and used at 1:250
dilution.
Immunohistochemistry and immunofluorescence
Immunohistochemical analysis was performed as previously
described protocol with modifications (McConnell et al.,
2011; Nandan et al., 2010, 2014). Intestinal tissues dissected
from mice were flushed with modified Bouine's fixative (50%
ethanol +5% acetic acid in water), then fixed overnight in 10%
buffered formalin (Fisher Scientific, PA, USA). The tissues
were then paraffin-embedded using an automated processor
and sectioned at 5 μm. The sections were then dried onto
charged slides and used for staining. The slideswere baked in a
65 °C oven for 1 h and were subsequently deparaffinized in
xylene. Sections were incubated in a 3% hydrogen peroxide in
methanol bath to block endogenous tissue peroxidases and
were then rehydrated by incubation in a decreasing alcohol
bath series (100%, 95%, 70%) followed by antigen retrieval
in citrate buffer solution (10 mM sodium citrate, 0.05%
Tween-20, pH 6.0) at 125 °C for 10 min using a decloaking
chamber (Biocare Medical, CA, USA). Tissue sections were first
incubated with blocking buffer (2.5% BSA in TBS-Tween)
for 30 min at 37 °C and then with primary antibody at 4 °C
overnight in a humidified chamber while shaking gently.
Sections were washed and incubated with secondary antibod-
ies (HRP-conjugated or fluorescent-tagged) at the appropriate
concentration for 30 min at 37 °C. Betazoid DAB (Biocare
Medical, CA, USA) was used to reveal IHC staining in tissues.
For fluorescent sections, slides were washed after secondary
antibody treatment and then stained with DAPI (Fisher
Scientific, PA, USA) and mounted with Prolong gold antifade
(Life Technologies, CA, USA). For EGFP co-staining with Klf5,
EGFP fluorescent secondary antibody detection was per-
formed first then followed by DAB for Klf5.
For Klf5/GFP/Ki-67 co-staining, slides were processed and
Klf5 antibody staining was performed overnight, as described
above. Mach3 rabbit AP polymer detection was applied to
slides as per protocol (Biocare Medical, CA, USA). Klf5 staining
was revealed using Warp Red chromogen (Biocare Medical,
CA, USA). Antibody elution was performed using previously
described protocol (Pirici et al., 2009). Slides were incubated
at 50 °C in Glycine-SDS (pH 2.0) solution with agitation for
1 h. Slides were then thoroughly washed with distilled water
and incubated with blocking buffer (2.5% BSA in TBS-Tween)
for 30 min at 37 °C. Then Ki–67 and GFP antibodies were
added and incubated at 37 °C for 1 h. Fluorescent detection
was performed with appropriate secondary antibodies before
staining with DAPI (Fisher Scientific, PA, USA) and mounted
with Prolong gold antifade (Life Technologies, CA, USA). Slides
were observed under a Nikon Eclipse 90i microscope (Nikon,
NY, USA) and representative pictures were taken. Morphology
of sections was observed upon staining 5 μm sections with
hematoxylin and eosin (H&E) (Vector Labs, CA, USA).
Statistical analysis
Statistical comparisons between Klf5 positive and Klf5/Ki-67
co-positive cells in EGFP+ and EGFP− crypts (50 randomly chosenfrom jejunum, n = 3) were performed using the paired 2-tailed
Student's t-test (n = 3). The number of EGFP positive crypts in
the Lgr5-Klf5fl/flmice upon chronic Klf5 deletion was compared
to Lgr5-Cre controls using 2-tailed Student's t-test (n = 3). Error
bars in all graphs represent the standard error of mean.Results
Klf5 is expressed in the stem cells of the mouse
small intestine and colon
Lgr5 has been recently identified as a marker for intestinal
stem cells through studies in an EGFP-tagged Lgr5-Cre mouse
model (Barker et al., 2007). Expression of Lgr5 is localized to
the actively and steadily proliferating columnar cells in the
crypt base (CBC cells) (Barker et al., 2007). Because of its
pro-proliferative effect, we first determined whether Klf5 is
also expressed in Lgr5-expressing CBC cells. As seen in Fig. 1,
Klf5 is localized in the nuclei throughout the crypt epithelial
zone of both small intestine and colon (Figs. 1A, C, D and F).
Lgr5-Cre (as marked by EGFP) is localized to the CBC cells in
both tissues (Figs. 1B, C, E and F). Importantly, Lgr5-positive
CBC cells in the small intestine and colon co-stained for Klf5
(Figs. 1C and F). It was noted that the Klf5 staining in the
CBC cells was weaker than that in the transit-amplifying (TA)
region located immediately above the stem cell zone.Klf5 is progressively lost from the CBC cells throughout
the entire intestinal crypt during short-term
treatment of Lgr5-Klf5fl/fl mice with tamoxifen
We then examined the effect of short-term or acute deletion of
Klf5 (up to 11 days) from Lgr5-positive CBC cells in Lgr5-Klf5fl/fl
mice treated with tamoxifen for five consecutive days (Suppl.
Fig. 1A). Tamoxifen-treated Lgr5-Cre mice served as controls.
There were no significant weight differences between
tamoxifen-treated Lgr5-Klf5fl/fl mice and control mice during
the acute period after tamoxifen treatment (data not shown).
Due to the relatively low penetrance of Lgr5-Cre expression,
deletion of Klf5was limited to 5–15% of the small intestinal and
colonic crypts. At day 0, both EGFP-stained green crypts (blue
box, representing Lgr5-Cre expressing crypts) and non-green
crypts (white box, representing crypts without Lgr5-Cre
expression) of Lgr5-Klf5fl/fl mice displayed Klf5 expression
(Fig. 2C and Suppl. Fig. 2C). At day 3 after the start of
tamoxifen treatment, there was a loss of Klf5 expression at the
bottom of green crypts corresponding to Lgr5-Cre green cells
(blue box) (Fig. 2F and Suppl. Fig. 2F) compared to adjoining
non-green crypts (white box). By 5 and 7 days post-tamoxifen
induction, loss of Klf5 expression was observed extending up
into the TA cell region and a large number of the Lgr5-Cre
positive green crypts have lost Klf5 expression (blue boxes),
compared to the non-green crypts (white boxes) (Figs. 2I, L and
Suppl. Figs. 2I, L). Complete or near complete loss of Klf5 in all
of the green crypts (blue boxes) compared to normal Klf5
expression in the non-green crypts (white boxes) was observed
11 days post-tamoxifen induction (Fig. 2O and Suppl. Fig. 2O).
No significant differences in Klf5 expression was observed in
the control mice at each time point (data not shown). Together
these results show an incremental loss of Klf5 starting from the
13Klf5 in intestinal stem cell proliferation and survivalCBC cells at day 3 and progressing upwards to the entire crypts
by day 11 post-tamoxifen treatment of Lgr5-Klf5fl/fl mice
(Suppl. Fig. 3). A similar trend was noted in the colonic tissues
of tamoxifen-treated Lgr5-Klf5fl/fl mice (Suppl. Fig. 2) and
Lgr5-Cre mice (data not shown).Loss of Klf5 from intestinal stem cells is accompanied
by a decrease in proliferation and an increase in
apoptosis of crypt epithelial cells
We previously established that Klf5, as a pro-proliferative
transcription factor (Sun et al., 2001; Nandan et al., 2004),
is often co-expressed with proliferation markers, such as
Ki-67 (Nandan et al., 2008). Consequently, we detected
consistent co-staining of Klf5 and Ki-67 in Lgr5-Klf5fl/fl mice
at day 0 in the crypt epithelial cell nuclei in both green and
non-green crypts (blue andwhite boxes) (Fig. 3D; Suppl. Fig. 4).
In the short-term tamoxifen treatment study, we noted a loss of
Ki-67 staining (Figs. 3G, K, O and S; Fig. 4; Suppl. Fig. 4) only in
the green crypts compared to the adjacent non-green crypts at
each time point post-tamoxifen induction of Lgr5-Klf5fl/flmice.
Simultaneously, there was a reduction in number of Klf5/Ki-67
co-stained nuclei from green crypts (blue boxes) compared to
adjacent non-green crypts (white boxes) (Figs. 3H, L, P and T;
Fig. 4; Suppl. Fig. 4). The control mice did not show any loss of
Klf5 or Ki-67 co-staining with tamoxifen treatment (data not
shown). These results indicate that the loss of proliferative cells
in the intestinal crypts is a consequence of Klf5 deletion fromFigure 1 Klf5 is expressed in the stem cell zone of the mouse gut. L
for both Klf5 and EGFP (representative of Lgr5 positive epithelial
panels D–F represent colonic tissues. Panels A and D show Klf5 stainin
B and E display EGFP stain using fluorescence appearing green. Panel
White arrows mark the cells that stain positive for both Klf5 and EGF
signifying the expression of Klf5 in the putative mouse gut epitheliaEGFP-positive stem cells (Fig. 4). Similar data were obtained
from the mouse colonic crypts (data not shown).
We then determined whether Klf5 loss from the intestinal
stem cells is accompanied by apoptosis by staining tissues for
cleaved caspase 3. We noticed increasing levels of cleaved
caspase 3 staining in intestinal crypts from Lgr5-Klf5fl/fl
mice (Figs. 5H, L, P and T) from 3 to 11 days following start
of tamoxifen treatment when compared to uninduced
control (Fig. 5D). It is interesting to note that a majority
of the Lgr5-positive green crypts, including green CBC cells,
displayed clear evidence of apoptosis at 7 and 11 days
post-tamoxifen treatment (Figs. 5P and T). There was no
induction of cleaved caspase 3 noted in the control mice upon
tamoxifen treatment (data not shown). Similar data was
obtained from tamoxifen-treated Lgr5-Klf5fl/fl and Lgr5-Cre
mouse colonic crypts (data not shown). These results suggest
that acute loss of Klf5 in intestinal crypt stem cells leads to a
loss of proliferation and apoptosis.
Deletion of Klf5 from EGFP-positive CBC cells results
in chronic loss of proliferation in stem cells
We examined the effect of chronic Klf5 deletion from
intestinal stem cells by extending the study period up to
112 days following tamoxifen treatment of Lgr5-Klf5fl/fl
mice. In Lgr5-Cre control mice treated with tamoxifen,
both EGFP-positive (blue arrows) and EGFP-negative crypts
(white arrows) co-stained for Klf5 and Ki-67 from days 14 to
112 following induction (Figs. 6D & L; Suppl. Fig. 5). Ingr5-Cre mouse small intestinal and colonic sections were stained
cells). Panels A–C represent mouse small intestinal crypts and
g using DAB chromogen which stains the nucleus red while panels
s C and F are merged images of respective Klf5 and EGFP panels.
P. There is consistent co-staining among Klf5 and EGFP proteins
l cells.
Figure 2 Tamoxifen induction results in Lgr5-driven Klf5 deletion in the small intestinal epithelium of Lgr5-Klf5fl/fl mice.
Representative images from untreated Lgr5-Klf5fl/fl (Panels A-C) followed by day 3, 5, 7 and 11 tamoxifen-treated Lgr5-Klf5fl/fl mice
jejunum (Panels D–O). Panels A, D, G, J and M show red DAB-stained nuclei representing Klf5 expression. Panels B, E, H, K and N show
EGFP fluorescent images (green stain) and panels C, F, I, L and O show merged images of both Klf5 and EGFP stains. Crypts marked in
the merged image by the blue boxes represent Lgr5-Cre positive green crypts, while the white boxes represent the non-green crypts.
Klf5 expression is incrementally lost in the green crypts beginning at day 3 to day 11.
14 M.O. Nandan et al.contrast, Klf5/Ki-67 co-staining was absent from the EGFP-
positive CBC stem cells (blue arrows) but present in the CBC
cells of the adjoining non-green crypts (white arrows)
(Figs. 6H & P; Suppl. Fig. 5) in Lgr5-Klf5fl/fl small intestinal
tissue. Of note is that there was a restoration of Klf5/Ki-67
co-positive staining in the transit-amplifying (TA) region of
the EGFP-positive crypts from day 14 to day 112 (Figs. 6H &
P; Suppl. Fig. 5). The results indicate that despite persistent
loss of proliferation of Lgr5-positive CBC cells due to Klf5
deletion, there is recovery of both Klf5 and Ki-67 expression
in the TA cell population immediately above the stem cell
zone during this time period.
Chronic deletion of Klf5 from Lgr5-Klf5fl/fl mouse
intestinal tissues results in depletion of EGFP-positive
Lgr5-Cre crypts
At 112 days post-tamoxifen treatment, we noted that there
was a significant reduction in the number of EGFP-positive
crypts in the small intestine and colon of Lgr5-Klf5fl/fl mice
when compared to day 14 of treatment, which in turn was
reduced when compared to Lgr5-Cre control mice (Suppl.
Fig. 6). This trend became apparent when we quantified and
compared the number of EGFP-positive crypts in the small
intestine and colon of mice from tamoxifen-treated
Lgr5-Klf5fl/fl and Lgr5-Cre mice from day 14 onwards
(Fig. 7). There was no difference in the number of greencrypts of Lgr5-Cre (control) tissues at any given time point
from the start of tamoxifen-treatment (Fig. 7). By day
112 post-tamoxifen treatment, approximately 90% of the
EGFP-positive crypts were depleted from the intestinal
tissues of Lgr5-Klf5fl/fl mice (Fig. 7). Hence, crypts that
sustained long-term loss of Klf5 resulted in the disappear-
ance of Lgr5-positive stem cells.
Discussion
The mammalian intestinal epithelium is among the most
rapidly proliferating tissue in the body and this fast turnover
helps protect the epithelial cells from genotoxic insults
(Podolsky, 1993; Booth and Potten, 2001). Our results show
that Klf5 is also expressed in the stem cells of the intestinal
epithelia. The intestinal crypt epithelial cells are innately
responsive to the Wnt pathway signals that regulate prolifer-
ation, cell fate and differentiation. Deregulation of the Wnt
signaling pathway, especially β-catenin and its modulator
proteins, is important for the initiation of tumorigenesis from
the normal epithelium (Korinek et al., 1997; Morin et al.,
1997; Barker et al., 2008).
Lgr5 was identified from a panel of Wnt target genes and
established as an intestinal stem cell marker (Barker et al.,
2007). Klf5 was also identified as a Wnt-responsive gene
(Ziemer et al., 2001) and facilitates β-catenin nuclear
translocation during Wnt pathway activation in intestinal
Figure 3 Loss of proliferation in crypts concomitant with Klf5 deletion in Lgr5-Klf5fl/fl mice. The panels are representative of
immunofluorescent staining of jejunal tissue from different time points after induction of tamoxifen in Lgr5-Klf5fl/fl mice. Panels A–D
represent control jejunum from uninduced Lgr5-Klf5fl/fl mice. Panels E–T represent jejunums collected from mice after 3, 5, 7 or
11 days following the start of tamoxifen treatment. Panels A, E, I, M and Q show immunofluorescent Klf5 staining in red, panels B, F,
J, N and R show EGFP expression in green and panels C, G, K, O and S show Ki-67 staining representative of proliferation in yellow.
Panels D, H, L, P and T are merged images of Klf5, EGFP and Ki-67 staining with Klf5/Ki-67 co-expression showing as orange stain. Blue
boxes in the merged image represent green crypts, while the white boxes represent the non-green crypts. Loss of Ki-67 expression
corresponds with loss of Klf5 staining in Lgr5-Klf5fl/fl mice after tamoxifen induction.
Figure 4 Klf5 and Ki-67 co-positive cell number is reduced in
Lgr5-Klf5fl/flmouse small intestinal tissue. Klf5/Ki-67 co-expressing
cells in the crypt are plotted on the Y-axis against days post-
tamoxifen-treatment on the X-axis. EGFP-positive green crypts
from Lgr5-Klf5fl/fl mice are represented as gray bars while non-
green crypts are represented as black bars. Klf5/Ki-67 co-positive
cells are reduced in Lgr5-Klf5fl/fl green crypts after tamoxifen
induction compared to non-green crypts. (**—p b 0.05).
15Klf5 in intestinal stem cell proliferation and survivalepithelial cells (McConnell et al., 2011). KLF5 has been
shown to be a transcription factor highly enriched in this
rapidly proliferating epithelial cells and its loss has been
associated with increased mortality and severe phenotypic
defects (McConnell et al., 2011; Shindo et al., 2002). The
current study shows that Klf5 is expressed in both the
intestinal stem cell and TA compartments and that Klf5
expression in the Lgr5-expressing stem cells is lower than
the adjoining TA epithelial cell compartment (Fig. 1). The
Lgr5-positive mouse intestinal stem cells are long-living and
cycle about every 22 h (Schepers et al., 2011). In contrast, the
TA cells are short-living, rapidly proliferate with a turnover
rate of 12 h and complete 4–5 rounds of cell division before
they differentiate and exit the crypts (Schepers et al., 2011).
We postulated that since Klf5 is intimately involved in
proliferation, its high expression is necessary for sustenance
and division of the short-living TA cell compartment. The stem
cells are relatively slower cycling compared to the TA cell
compartment and hence express lower levels of Klf5 (Fig. 1).
In this study, we were able to successfully delete Klf5 from
the Lgr5-expressing intestinal stem cells in adult mice. The
short-term effect of Klf5 deletion in the intestinal and colonic
stem cells was a gradual disappearance of Klf5 expression
starting in the EGFP-positive stem cells and moving upwards,
eventually resulting in total loss of Klf5 expression from the
entire crypt at 11 days post-tamoxifen treatment (Fig. 2;
Suppl. Fig. 2). This result supports the lineage tracing
Figure 5 Increase in apoptotic cells upon acute Klf5 deletion in Lgr5-Klf5fl/fl small intestinal crypt stem cells. Apoptosis in jejunal
crypts is represented by positive cleaved caspase 3 staining. Staining of control jejunum from uninduced Lgr5-Klf5fl/fl mice is
represented in panels A–D. Jejunums collected from mice after 3, 5, 7 and 11 days following the start of tamoxifen treatment are
represented in panels E through T. Panels A, E, I, M and Q show nuclear DAPI staining in blue, panels B, F, J, N and R show EGFP
expression in green and panels C, G, K, O and S show cleaved caspase 3 staining in red. Panels D, H, L, P and T are merged images of
cleaved caspase 3, EGFP and DAPI stains where yellow staining represents EGFP stained stem cells that are positive for cleaved
caspase 3. EGFP-positive crypts are marked with a yellow box while non-green crypts are marked with a white box, in the merged
images. Klf5 deletion results in increased apoptosis in the stem cell zone of Lgr5-Klf5fl/fl mice after tamoxifen induction compared
with uninduced controls.
16 M.O. Nandan et al.studies with the Lgr5-Cre mice where daughter cells arising
from the stem cells give rise to adjoining TA cells and migrate
towards the villus (Barker et al., 2007). Tamoxifen-treated
Lgr5-Klf5fl/fl mice do not display the morbidity or mortality
associated with complete embryonic deletion of Klf5
(McConnell et al., 2011; Shindo et al., 2002), possibly due to
the low penetrance of Lgr5-Cre expression. These Lgr5-Klf5fl/fl
mice do show a loss of proliferation in the crypts corresponding
with Klf5 loss (Figs. 3 and 4; Suppl. Fig. 4). We also noted that
the EGFP-positive crypts display an increase in apoptotic cells
that accompany Klf5 loss (Fig. 5). The combinatorial loss of
proliferation and increased apoptosis in crypts following the
loss of Klf5 suggests that Klf5 is crucial for the maintenance of
intestinal stem cells in vivo.
The effect of chronic Klf5 deletion in the intestinal stem
cells was studied for 112 days after tamoxifen treatment.
We observed prolonged loss of Klf5 and Ki-67 expression in
the EGFP-positive crypt stem cells for the duration of the
study (Fig. 6; Suppl. Fig. 5). However, both Klf5 and Ki-67
expression recovered in the TA cell compartment by 14 days
post-tamoxifen treatment and continued till 112 days. We also
noted a progressive decrease in the number of EGFP-positive
crypts in the intestinal tissues of tamoxifen-treated Lgr5-Klf5fl/
fl mice (Fig. 7; Suppl. Fig. 6). About 80–90% of small intestinaland colonic EGFP-positive crypts were lost in the tamoxifen-
treated Lgr5-Klf5fl/fl tissues when compared with the
tamoxifen-treated Lgr5-Cre tissues (Fig. 7; Suppl. Fig. 6). This
result suggests that the non-dividing stem cell population
caused by Klf5 deletion has a finite life-time, after which
they become depleted. Apart from the gradual loss of
EGFP-positive crypts from Lgr5-Klf5fl/fl tissues, we also
observed a decrease in number of EGFP-positive cells per
EGFP-positive crypt (data not shown). These results,
together with the re-occurrence of Klf5 and Ki67 positive
cells in the TA cells, support a model where the prolonged
loss of Klf5 expression from intestinal stem cells results in
their gradual replacement by alternative sources that serve
as a reserve. A mouse model with a more robust intestinal
stem cell-specific Cre recombinase expression could po-
tentially display catastrophic consequences upon Klf5 loss.
Our understanding of intestinal stem cells and theirmodes of
action has been considerably expanded. The +4 label retaining
cell population that was once considered as the stem cells
(Sangiorgi and Capecchi, 2008) has been rechristened as the
quiescent stem cells expressing Bmi1, among other factors
(Munoz et al., 2012; Li and Clevers, 2010). The Bmi1-labeled
quiescent stem cells have gained a new identity as a reserve
stem cell population that can get induced upon intestinal injury
Figure 6 Klf5 deletion in Lgr5-Klf5fl/fl mice persists long-term in Lgr5-Cre positive green crypts. The top and bottom set of images
are representative small intestinal tissue from Lgr5-Cre control and Lgr5-Klf5fl/fl mice after 14 days and 112 days of tamoxifen
treatment, respectively. Panels A–D and I–L are representative of staining from tissue collected from Lgr5-Cre control mice while
panels E–H and M–P show staining representative of Lgr5-Klf5fl/fl mice. Panels A, E, I and M display Klf5 immunofluorescent staining in
red; panels B, F, J and N show EGFP staining in green; panels C, G, K and O show Ki-67 staining in yellow and panels D, H, L and P show
merged images of Klf5, EGFP and Ki-67 stains. Blue arrows point to green crypts while white arrows point to non-green crypts in the
merged images. Lgr5-Klf5fl/fl mice show long-term loss of Klf5 only in the EGFP labeled CBC cells.
17Klf5 in intestinal stem cell proliferation and survivaland replace the underlying Lgr5 stem cell population (Yan et
al., 2012). In the current model, whether cells expressing Bmi1
or other known quiescent stem cell marker may serve as theFigure 7 Loss of Lgr5-positive green crypts in Lgr5-Klf5fl/fl mice
crypts is graphically represented in panels A & B with number of EGFP
on the X-axis. Quantitation of jejunal tissues are represented in pan
mice are represented as black bars while Lgr5-Klf5fl/fl tissues are sho
of green crypts at day 0, while there is a steady decrease in EGFP-po
intestinal and colonic tissues. Results are the average of four sectiosource of crypt cell replacement in crypts that have lost Klf5
from the Lgr5-expressing stem cell population is an open
question that begs further investigation.upon chronic Klf5 deletion. Quantitation of Lgr5-positive green
positive crypts on the Y-axis and days post-tamoxifen treatment
el A and colonic tissues in panel B. Tissues from control Lgr5-Cre
wn as gray bars in both panels. There is no change in the number
sitive crypt count starting from day 14 till day 112 in both small
ns assayed from two independent experiments. ** p b 0.05.
18 M.O. Nandan et al.A recent study (Nakaya et al., 2014), published during the
preparation of this manuscript, has reported similar defects
upon Lgr5-mediated loss of Klf5 in mice. They observed that
Klf5 was obligatory for survival and transformation of intestinal
epithelial cells. They also showed a reduction of proliferation
and increase in apoptotic bodies upon Klf5 deletion from the
intestinal stem cells that was dependent on nuclear localiza-
tion of β-catenin (Nakaya et al., 2014). The authors further
defined the importance of Klf5 expression in promoting Apc/
β-catenin mediated tumorigenesis. They postulated that Klf5
was a regulator of homeostatic and neoplastic proliferation in
intestinal epithelial cells (Nakaya et al., 2014).
Our study reports that the loss of Klf5 from intestinal
stem cells leads to reduction in proliferation eventually
resulting in the loss of stem cells. We propose three possible
outcomes of Klf5 deletion in stem cells that could elucidate
our findings. Firstly, the replenishment of the TA cell
population in the EGFP positive crypts could be due to drift
from the adjoining non green crypt stem cells. Secondly, the
pre-existing quiescent stem cell (Bmi1+) population could
be activated due to the lack of proliferation from the native
stem cell population and function as the source of TA cell
population. Thirdly, in conjunction with the emerging “neutral
drift” model for competing stem cells (Snippert et al., 2010;
Lopez-Garcia et al., 2010), equipotent competition of stem
cells within the EGFP positive crypts could result in clonality
arising from a neighboring unlabeled stem cell. The identity of
the origin of these replacing crypt epithelial cells remains to be
explored.Conclusion
We have shown that intestinal stem cell proliferation is
dependent on Klf5 expression. Stem cells that have lost Klf5
expression show an increase in apoptotic bodies. Disappear-
ance of stem cells was observed as a chronic consequence of
Klf5 deletion. Overall, our study shows that Klf5 is necessary
and critical for the survival of intestinal crypt cells.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.10.008.Acknowledgments
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